Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 126,656 | 115,177 | 130,234 | 109,976 | 99,651 |
| Cost of Goods | 31,051 | 26,796 | 29,198 | 28,696 | 27,769 |
| Gross Profit | 95,605 | 88,381 | 101,036 | 81,280 | 71,882 |
| Operating Expenses | 85,437 | 82,935 | 115,126 | 85,828 | 73,920 |
| Operating Income | 10,219 | 6,242 | -13,892 | -3,852 | -1,269 |
| Other Income | 34 | -419 | -648 | -491 | -528 |
| Pre-tax Income | 10,253 | 5,823 | -14,540 | -4,343 | -1,797 |
| Income Tax | 2,580 | -6,508 | 2,503 | -2,243 | -1,228 |
| Net Income Continuous | 7,673 | 12,331 | -17,043 | -2,100 | -569 |
| Net Income | $7,673 | $12,331 | $-17,043 | $-2,100 | $-569 |
| EPS Basic Total Ops | 0.05 | 0.09 | -0.13 | -0.02 | N/A |
| EPS Basic Continuous Ops | 0.06 | 0.09 | -0.13 | -0.02 | 0.00 |
| EPS Diluted Total Ops | 0.05 | 0.09 | -0.13 | -0.02 | N/A |
| EPS Diluted Continuous Ops | 0.06 | 0.09 | -0.13 | -0.02 | 0.00 |
| EPS Diluted Before Non-Recurring Items | 0.04 | 0.09 | -0.13 | N/A | N/A |
| EBITDA(a) | $16,639 | $12,659 | $-7,531 | $2,324 | $5,062 |